“…It has been widely studied in the treatment of breast cancers. , In particular, the recent emergence of aggregation-induced emission luminogens (AIEgens) based photosensitizers (AIE-PS), − which exhibited enhanced fluorescence intensity and efficient ROS generation in the aggregated state, has accelerated the development of PDT. Our group has successfully synthesized a series of AIE-PS for various biomedicine applications. − For instance, an AIE-PS (LIQ-TPA-DTZ) with high quantum yield, 1 O 2 and ·OH generation efficiency was recently reported to induce effective PDT . Unfortunately, like most PSs, LIQ-TPA-DTZ also suffered from the disadvantages of poor water solubility, low photostability, dark cytotoxicity, rapid clearance, and lack of cancer targeting in vivo, which made its anticancer treatment only could be achieved by intertumoral administration in the previous study …”